ホーム › 転移性癌 › バージニア › Arlington
Arlington、VAにおける転移性癌の臨床試験
Arlingtonとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する53件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
被験者募集中第3相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- Inova Fairfax Hospital, Falls Church · 4マイル先
- Inova Schar Cancer Institute, Fairfax · 11マイル先
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
- NEXT Virginia, Fairfax · 11マイル先
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
被験者募集中第1/2相
- NEXT Oncology, Fairfax · 11マイル先
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11マイル先
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
被験者募集中第1相
- ALX Center 2, Fairfax · 11マイル先
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
被験者募集中第2/3相
- Virginia Cancer Specialists - Fairfax Office, Fairfax · 11マイル先
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11マイル先
- Virginia Cancer Specialists, PC, Reston · 14マイル先
- 他1件
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
被験者募集中第3相
- Research Site, Fairfax · 11マイル先
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
被験者募集中第2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
被験者募集中第1/2相
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- Next Oncology Virginia Cancer Specialist, Fairfax · 11マイル先
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
被験者募集中第1/2相
- Virginia Cancer Specialists, PC, Fairfax · 11マイル先
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- USO-Virginia Cancer Specialists, PC, Fairfax · 11マイル先
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- USO - Virginia Cancer Specialists, Fairfax · 11マイル先
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
被験者募集中第1相
- NEXT, Fairfax · 11マイル先
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
被験者募集中第1/2相
- Avenzo Therapeutics Recruiting Site, Fairfax · 11マイル先
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
被験者募集中第1/2相
- Crinetics Study Site, Fairfax · 11マイル先
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
被験者募集中第3相
- Research Site, Falls Church · 4マイル先
- Research Site, Fairfax · 11マイル先
A Study of ASP1002 in Adults for Treatment of Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of PYX-201 in Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study of LY4175408 in Participants With Advanced Cancer
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Fairfax · 11マイル先
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, Fairfax · 11マイル先
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
被験者募集中第1/2相
- NEXT Oncology, Fairfax · 11マイル先
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
被験者募集中第1相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Next Oncology Virginia, Fairfax · 11マイル先
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
被験者募集中第2/3相
- Inova Schar Cancer, Fairfax · 11マイル先
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virigina, Fairfax · 11マイル先
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
被験者募集中第1/2相
- NEXT Virginia, Fairfax · 11マイル先
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- Los Angeles, CA57件の研究
- St. Louis, MO54件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
- Seattle, WA39件の研究
Arlingtonにおける他の研究
- 非小細胞肺癌104件の研究
- 大腸癌52件の研究
- がん（全種類）48件の研究
- 乳がん47件の研究
- 卵巣がん46件の研究
- 肺がん41件の研究
- 子宮内膜がん39件の研究
- 膵臓がん33件の研究
- 頭頸部扁平上皮癌26件の研究
- 小細胞肺がん23件の研究
- 胃癌20件の研究
- トリプルネガティブ乳がん20件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。